Literature DB >> 27776072

Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses.

.   

Abstract

Adnexal masses (ie, masses of the ovary, fallopian tube, or surrounding tissues) commonly are encountered by obstetrician-gynecologists and often present diagnostic and management dilemmas. Most adnexal masses are detected incidentally on physical examination or at the time of pelvic imaging. Less commonly, a mass may present with symptoms of acute or intermittent pain. Management decisions often are influenced by the age and family history of the patient. Although most adnexal masses are benign, the main goal of the diagnostic evaluation is to exclude malignancy. The purpose of this document is to provide guidelines for the evaluation and management of adnexal masses in adolescents, pregnant women, and nonpregnant women and to outline criteria for the identification of adnexal masses that are likely to be malignant and may warrant referral to or consultation with a gynecologic oncologist.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27776072     DOI: 10.1097/AOG.0000000000001768

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  37 in total

1.  Characterization of Adnexal Masses Using Contrast-Enhanced Subharmonic Imaging: A Pilot Study.

Authors:  Lauren J Delaney; Priscilla Machado; Mehnoosh Torkzaban; Andrej Lyshchik; Corinne E Wessner; Christine Kim; Norman Rosenblum; Scott Richard; Kirk Wallace; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2019-11-26       Impact factor: 2.153

2.  Diagnosing ovarian cancer.

Authors:  Melissa Walker; Mara Sobel
Journal:  CMAJ       Date:  2018-10-22       Impact factor: 8.262

3.  A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study.

Authors:  Róisín O'Flaherty; Mohankumar Muniyappa; Ian Walsh; Henning Stöckmann; Mark Hilliard; Richard Hutson; Radka Saldova; Pauline M Rudd
Journal:  Mol Cell Proteomics       Date:  2019-08-30       Impact factor: 5.911

4.  [Diagnostic value of CA125, HE4 and Copenhagen Index in differentiating benign from malignant epithelial ovarian tumors].

Authors:  Shi-Peng Gong; Yong-Ning Chen; Ya-di Zhang; Wei Yao; Li Chen; Shi-San Liu; Huan Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

5.  Risk of Malignant Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population.

Authors:  Rebecca Smith-Bindman; Liina Poder; Eric Johnson; Diana L Miglioretti
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

Review 6.  Gynecologic cancer in pregnancy.

Authors:  Travis-Riley K Korenaga; Krishnansu S Tewari
Journal:  Gynecol Oncol       Date:  2020-04-05       Impact factor: 5.482

7.  Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers.

Authors:  Burton S Brodsky; Gary M Owens; Dennis J Scotti; Keith A Needham; Christina L Cool
Journal:  Am Health Drug Benefits       Date:  2017-10

8.  Variation in Oophorectomy Rates for Children with Ovarian Torsion across US Children's Hospitals.

Authors:  Susan C Lipsett; Lalita Haines; Michael C Monuteaux; Katherine Hayes; Kenneth A Michelson
Journal:  J Pediatr       Date:  2020-12-17       Impact factor: 4.406

Review 9.  ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors.

Authors:  Dirk Timmerman; François Planchamp; Tom Bourne; Chiara Landolfo; Andreas du Bois; Luis Chiva; David Cibula; Nicole Concin; Daniela Fischerova; Wouter Froyman; Guillermo Gallardo Madueño; Birthe Lemley; Annika Loft; Liliana Mereu; Philippe Morice; Denis Querleu; Antonia Carla Testa; Ignace Vergote; Vincent Vandecaveye; Giovanni Scambia; Christina Fotopoulou
Journal:  Int J Gynecol Cancer       Date:  2021-06-10       Impact factor: 3.437

10.  Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors.

Authors:  Hung Shen; Heng-Cheng Hsu; Yi-Jou Tai; Kuan-Ting Kuo; Chia-Ying Wu; Yen-Ling Lai; Ying-Cheng Chiang; Yu-Li Chen; Wen-Fang Cheng
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.